If logic has anything to do with it, blinatumomab's commercial potential has been recognised and that means it looks like it's going to be a BLOCKBUSTER.
If logic has nothing to do with it then we can expect to see the price fall due to short-termists prematurely cashing in their shares and so missing out on the huge upside.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.